%0 Journal Article
%K Cprd
%K Immune checkpoint inhibitors
%K Lung cancer
%K Study eligibility
%K Tyrosine kinase inhibitors
%B Cancer Epidemiol
%D 2022
%G eng
%M 35429893
%P 102149
%R 10.1016/j.canep.2022.102149
%T Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors
%V 78
%7 2022/04/17
%@ 1877-7821